| scholarly article | Q13442814 |
| P2093 | author name string | Xin Zhou | |
| Xinxin Ding | |||
| Fang Xie | |||
| Xiaoliang Zhuo | |||
| W Griffith Humphreys | |||
| Kerri Kluetzman | |||
| Yue-Zhong Shu | |||
| P2860 | cites work | Organization and evolution of the Cyp2 gene cluster on mouse chromosome 7, and comparison with the syntenic human cluster | Q24816889 |
| Human flavin-containing monooxygenase: substrate specificity and role in drug metabolism | Q28207851 | ||
| N-glucuronidation of nicotine and cotinine by human liver microsomes and heterologously expressed UDP-glucuronosyltransferases | Q28211554 | ||
| Validation and application of a method for the determination of nicotine and five major metabolites in smokers' urine by solid-phase extraction and liquid chromatography-tandem mass spectrometry | Q33210890 | ||
| Metabolism and disposition kinetics of nicotine | Q34398241 | ||
| Nicotine glucuronidation and the human UDP-glucuronosyltransferase UGT2B10. | Q34638862 | ||
| Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment | Q35111748 | ||
| Regulation of the cytochrome P450 2A genes | Q35886032 | ||
| Nicotine neuroprotection against nigrostriatal damage: importance of the animal model | Q36782419 | ||
| High abundance of testosterone and salivary androgen-binding protein in the lateral nasal gland of male mice | Q37359671 | ||
| Molybdenum hydroxylases: biological distribution and substrate-inhibitor specificity | Q39704403 | ||
| Cytochrome P450 2A-catalyzed metabolic activation of structurally similar carcinogenic nitrosamines: N'-nitrosonornicotine enantiomers, N-nitrosopiperidine, and N-nitrosopyrrolidine | Q42042660 | ||
| Gene family of male-specific testosterone 16 alpha-hydroxylase (C-P-450(16) alpha) in mouse liver: cDNA sequences, neonatal imprinting, and reversible regulation by androgen | Q42648574 | ||
| Targeted disruption of the MHC class II Aa gene in C57BL/6 mice | Q42809952 | ||
| Cotinine binding to nicotinic acetylcholine receptors in bovine chromaffin cell and rat brain membranes | Q43638211 | ||
| Induction of CYP2B1/2 and nicotine metabolism by ethanol in rat liver but not rat brain | Q43764263 | ||
| Total cotinine in plasma: a stable biomarker for exposure to tobacco smoke | Q44156717 | ||
| Microsomal N-glucuronidation of nicotine and cotinine: human hepatic interindividual, human intertissue, and interspecies hepatic variation | Q44217904 | ||
| Targeted Disruption of the Olfactory Mucosa-SpecificCyp2g1Gene: Impact on Acetaminophen Toxicity in the Lateral Nasal Gland, and Tissue-Selective Effects onCyp2a5Expression | Q44650613 | ||
| Metabolism of nicotine by human liver microsomes: stereoselective formation of trans-nicotine N'-oxide | Q45264840 | ||
| CYP2A6 genotype and the metabolism and disposition kinetics of nicotine. | Q46189862 | ||
| Nicotine 5'-oxidation and methyl oxidation by P450 2A enzymes | Q46463084 | ||
| Nicotine metabolism and urinary elimination in mouse: in vitro and in vivo | Q46837480 | ||
| Nicotine self-administration in mice is associated with rates of nicotine inactivation by CYP2A5. | Q46950227 | ||
| Mouse liver cytochrome P-450 (P-450IIIAM1): its cDNA cloning and inducibility by dexamethasone | Q48178043 | ||
| Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats | Q48208417 | ||
| Nicotine is more efficient than cotinine at passing the blood-brain barrier in rats. | Q48468409 | ||
| Immunochemical characterization of multiple forms of cytochrome P-450 in rabbit nasal microsomes and evidence for tissue-specific expression of P-450s NMa and NMb. | Q49045714 | ||
| Development and evaluation of a candidate reference measurement procedure for the determination of progesterone in human serum using isotope-dilution liquid chromatography/tandem mass spectrometry. | Q51786502 | ||
| Characterization and comparison of nicotine and cotinine metabolism in vitro and in vivo in DBA/2 and C57BL/6 mice. | Q51909129 | ||
| A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. | Q52275435 | ||
| Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes | Q59153191 | ||
| Purification and characterization of two unique forms of cytochrome P-450 from rabbit nasal microsomes | Q68060984 | ||
| Role of human cytochrome P4502A6 in C-oxidation of nicotine | Q71820851 | ||
| Nicotine metabolism by rat hepatic cytochrome P450s | Q72825656 | ||
| Steroid metabolism by rabbit olfactory-specific P450 2G1 | Q72871282 | ||
| Cytochrome P450 and steroid hydroxylase activity in mouse olfactory and vomeronasal mucosa | Q73226374 | ||
| Nicotine metabolism and intake in black and white smokers | Q74788995 | ||
| Expression of cytochrome p450 and other biotransformation genes in fetal and adult human nasal mucosa | Q80367595 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nicotine | Q12144 |
| P304 | page(s) | 578-587 | |
| P577 | publication date | 2009-11-18 | |
| P1433 | published in | Journal of Pharmacology and Experimental Therapeutics | Q1500272 |
| P1476 | title | Role of CYP2A5 in the clearance of nicotine and cotinine: insights from studies on a Cyp2a5-null mouse model | |
| P478 | volume | 332 |
| Q34715641 | A novel defensive mechanism against acetaminophen toxicity in the mouse lateral nasal gland: role of CYP2A5-mediated regulation of testosterone homeostasis and salivary androgen-binding protein expression. |
| Q35642381 | Absence of cytochrome P450 2A5 enhances alcohol-induced liver injury in mice |
| Q94044432 | Alcohol Upregulation of CYP2A5: Role of Reactive Oxygen Species |
| Q46683742 | Alcoholic Liver Disease: from CYP2E1 to CYP2A5. |
| Q51164359 | Alcoholic fatty liver is enhanced in CYP2A5 knockout mice: The role of the PPARα-FGF21 axis. |
| Q36146886 | An LC-MS/MS method for concurrent determination of nicotine metabolites and the role of CYP2A6 in nicotine metabolite-mediated oxidative stress in SVGA astrocytes |
| Q52316734 | CYP2A6 is associated with obesity: studies in human samples and a high fat diet mouse model. |
| Q34946016 | Characterization of CYP2B6 in a CYP2B6-humanized mouse model: inducibility in the liver by phenobarbital and dexamethasone and role in nicotine metabolism in vivo |
| Q54238017 | Cytochrome P450s And Alcoholic Liver Disease. |
| Q37425440 | Direct quantitative analysis of nicotine alkaloids from biofluid samples using paper spray mass spectrometry |
| Q34513706 | Drug-metabolizing enzyme, transporter, and nuclear receptor genetically modified mouse models |
| Q64091763 | Dynamic changes in lung responses after single and repeated exposures to cigarette smoke in mice |
| Q53331248 | Effects of Fatty Acids on CYP2A5 and Nrf2 Expression in Mouse Primary Hepatocytes. |
| Q39878597 | Effects of cigarette smoke, cessation and switching to a candidate modified risk tobacco product on the liver in Apoe -/- mice--a systems toxicology analysis |
| Q38715117 | Enduring Effects of Perinatal Nicotine Exposure on Murine Sleep in Adulthood. |
| Q37422689 | Essential role of the cytochrome P450 enzyme CYP2A5 in olfactory mucosal toxicity of naphthalene |
| Q34551942 | Ethanol induction of CYP2A5: permissive role for CYP2E1 |
| Q36383661 | Ethanol induction of CYP2A5: role of CYP2E1-ROS-Nrf2 pathway |
| Q35996452 | Generation and characterization of a CYP2A13/2B6/2F1-transgenic mouse model |
| Q35265554 | Generation and characterization of a Cyp2f2-null mouse and studies on the role of CYP2F2 in naphthalene-induced toxicity in the lung and nasal olfactory mucosa |
| Q33942976 | Generation and characterization of a novel CYP2A13--transgenic mouse model |
| Q36497642 | Generation and characterization of a novel Cyp2a(4/5)bgs-null mouse model |
| Q84019090 | Generation of a mouse model with a reversible hypomorphic cytochrome P450 reductase gene: utility for tissue-specific rescue of the reductase expression, and insights from a resultant mouse model with global suppression of P450 reductase expression |
| Q37948908 | Humanized transgenic mouse models for drug metabolism and pharmacokinetic research |
| Q34434931 | Identification of cytochrome P450 enzymes critical for lung tumorigenesis by the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK): insights from a novel Cyp2abfgs-null mouse |
| Q37331804 | Impact of nicotine metabolism on nicotine's pharmacological effects and behavioral responses: insights from a Cyp2a(4/5)bgs-null mouse |
| Q34208914 | Mechanisms of olfactory toxicity of the herbicide 2,6-dichlorobenzonitrile: essential roles of CYP2A5 and target-tissue metabolic activation |
| Q26784043 | Nicotine: Carcinogenicity and Effects on Response to Cancer Treatment - A Review |
| Q39003382 | Omega-3 Polyunsaturated Fatty Acids Protect Against Cigarette Smoke-Induced Oxidative Stress and Vascular Dysfunction |
| Q35846884 | Respective roles of CYP2A5 and CYP2F2 in the bioactivation of 3-methylindole in mouse olfactory mucosa and lung: studies using Cyp2a5-null and Cyp2f2-null mouse models |
| Q37412014 | Role of CYP2A13 in the bioactivation and lung tumorigenicity of the tobacco-specific lung procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: in vivo studies using a CYP2A13-humanized mouse model |
| Q35847688 | Role of CYP2A5 in the bioactivation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice |
| Q46838798 | Smilax China root extract detoxifies nicotine by reducing reactive oxygen species and inducing CYP2A6. |
| Q92399219 | Suppressed hepatocyte proliferation via a ROS-HNE-P21 pathway is associated with nicotine- and cotinine-enhanced alcoholic fatty liver in mice |
| Q36437214 | The role of CYP2A5 in liver injury and fibrosis: chemical-specific difference |
| Q35002458 | The tissue-specific toxicity of methimazole in the mouse olfactory mucosa is partly mediated through target-tissue metabolic activation by CYP2A5 |
| Q35084940 | Toxicity of gutkha, a smokeless tobacco product gone global: is there more to the toxicity than nicotine? |
| Q36455137 | Toxicity of nicotine by repeated intratracheal instillation to f344 rats |
| Q37253522 | Transcriptional suppression of CYP2A13 expression by lipopolysaccharide in cultured human lung cells and the lungs of a CYP2A13-humanized mouse model |
Search more.